DEMEETRA AGBIO
Demeetra AgBio is the issuance of licenses for agriculture, industrial biotechnology, and pharmaceutical bioprocessing.
DEMEETRA AGBIO
Industry:
Agriculture Biotechnology Market Research Pharmaceutical
Founded:
2019-01-01
Address:
Lexington, Kentucky, United States
Country:
United States
Website Url:
http://www.demeetra.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Content Delivery Network Global Site Tag Yoast WordPress SEO Plugin GoDaddy SSL GoDaddy WooCommerce Checkout BbPress Active Campaign PowerPack For Beaver Builder WooCommerce 4.6
Current Employees Featured
Official Site Inspections
http://www.demeetra.com Semrush global rank: 1.02 M Semrush visits lastest month: 33.31 K
- Host name: 79.0.153.160.host.secureserver.net
- IP address: 160.153.0.79
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Demeetra AgBio"
Gene Editing Technologies - Demeetra
Demeetra AgBio holds exclusive licenses to gene editing technologies Cas-CLOVER and piggyBac transposase for research and commercial fields in agriculture, industrial biotech and โฆSee details»
Demeetra AgBio - Crunchbase Company Profile & Funding
Demeetra AgBio is the issuance of licenses for agriculture, industrial biotechnology, and pharmaceutical bioprocessing. View contacts for Demeetra AgBio to access new leads and โฆSee details»
Commercial licenses with freedom to operate - Demeetra
Demeetra AgBio, Inc., holds the exclusive licenses for the gene editing technologies Cas-CLOVER and piggyBac transposase, for use in research and commercial applications in โฆSee details»
Demeetra Company Profile 2024: Valuation, Funding
Demeetra General Information Description. Developer of gene-editing technology designed for research and commercial fields in agriculture, industrial biotech, โฆSee details»
Demeetra - LinkedIn
Demeetra | 456 followers on LinkedIn. Gene Editing Without Limits: Freedom To Operate. Guided Expertise. | Centrally located in the Bluegrass State of Kentucky, Demeetra has built extensive โฆSee details»
Demeetra AgBio, Inc. - BIO International Convention | BIO
Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Demeetra โฆSee details»
Demeetra AgBio - Crunchbase
Demeetra AgBio is the issuance of licenses for agriculture, industrial biotechnology, and pharmaceutical bioprocessing.See details»
Demeetra | Cell & Gene Therapy International
Demeetra provides solutions to the biggest challenges facing our clients when adopting CRISPR & transposase technology for commercial cell line development. By combining our own Cas โฆSee details»
Demeetra AgBio - Updates, News, Events, Signals & Triggers
Demeetra AgBio may be growing as the company is associated with Cas-CLOVER, an advanced gene editing technology that is highlighted for its capability to meet crop improvement โฆSee details»
Jack Crawford - Demeetra | Cell & Gene Therapy International โฆ
Jack Crawford is the founding CEO of Demeetra. As CEO, Jack is focused on providing partners with commercially applicable gene editing technologies through simple accessible licenses. โฆSee details»
CRISPR Medicine News Interview with Demeetra AgBio CEO, Jack โฆ
Jun 14, 2021 Demeetra Agbio, a Rapha portfolio company was recently featured in an article in the leading industry publication, CRISPR News MEDICINE. Demeetra AgBio, headquartered โฆSee details»
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing โฆ
Sep 14, 2023 Demeetra, headquartered in Kentucky, is a biotechnology company whose core focus is developing and optimizing gene editing technologies in commercially applicable โฆSee details»
Company: Demeetra AgBio - CRISPR Medicine
Demeetra Agbio is a privately held agricultural and therapeutic gene-editing company. Based in Kentrucky, US, the company utilises its proprietary Cas-CLOVER platform to genetically โฆSee details»
Demeetra AgBio Advances Major Pipeline for Therapeutic
Jun 16, 2021 Demeetra is advancing a pipeline of therapeutic cannabinoids and plans to file an IND in Q1 of 2022 for its lead candidate. ... Organization Profile. Demeetra AgBio. Contact โฆSee details»
As FDA considers Cutting Nicotine in Cigarettes, Demeetra
Jun 15, 2021 Demeetra AgBio is open for licensing and services to modify any tobacco strain, variety, or other crop with its precise gene editing technology. ... Organization Profile. โฆSee details»
Jack Crawford's lab - ResearchGate
At Demeetra AgBio, our mission is to advance gene editing in plants, yeast and CHO cells for biotherapeutic manufacturing and crop trait development. We are working to optimize our โฆSee details»
Demeetraโs Complementary Gene Editing Technologies
Jun 10, 2024 Demeetra is a biotechnology company specializing in gene editing technologies with commercial freedom to operate. Our extensive expertise complements both our internally โฆSee details»
โthe clean alternative to CRISPR/Cas9โ with Cas-CLOVER
Demeetra developed a proprietary method protocol which is transferred to our licensees and partners 6 New protocol yields 90%+ genome editing efficiency and white shoots/total shoots โฆSee details»
Designing Cas-CLOVER: a dimeric RNA guided targeted - Demeetra
Www.demeetra.com Figure 3: Cas-CLOVER KO ef๏ฌciency at different gap lengths Clo051-G4S-dCas Clo051-(G4S)โ-dCas Demeetra only provides the Cas-CLOVER mRNA as a reagent and โฆSee details»
Demeetra (@DemeetraAgbio) / Twitter
Mar 26, 2020 Demeetraโs advanced gene editing technology enables researchers to make targeted knockouts and insertions. This scarless gene editing means no heterologous genes โฆSee details»